Clinical Catalyst Radar for Biotech
Pricing
Pay per usage
Go to Apify Store
Clinical Catalyst Radar for Biotech
For each biotech company, correlates clinical pipeline progress (ClinicalTrials.gov) and research momentum (PubMed) with open-market insider buying (SEC Form 4), scores convergence 0 to 100, and tiers companies catalyst, clinical lead, insider lead, or watch. An advancing asset plus insiders buying.